$GALE Company News Top longs and shorts to watch 12:18

New Post Public Reply Private Reply Replies (0) Message Board

Jan 3, 2014 at 11:13 AM

$GALE Company News

Top longs and shorts to watch 12:18 p.m. March 6, 2012 - The Trading Deck

Biotech Stocks Under $10 With Huge Upside Potential for 2014 7:39 a.m. Today - 247WallSt.com
Galena Biopharma rallies, SA bull upbeat for 2014 3:02 p.m. Dec. 31, 2013 - Seeking Alpha
The Young And Restless Portfolio Update: Heading Into 2014 After A Fabulous 2013 10:07 a.m. Dec. 31, 2013 - Seeking Alpha
Galena Biopharma Inc. (GALE) Shares March Higher, Can It Continue? - Tale of the Tape 8:41 a.m. Dec. 31, 2013 - Zacks.com
Team Alpha Portfolio Updates: 2014 Could Be The Year Of The Dividend Champs 9:00 a.m. Dec. 30, 2013 - Seeking Alpha
Ten Top Stocks Trading Under $10 to Buy for Big 2014 Gains 6:12 a.m. Dec. 27, 2013 - 247WallSt.com
Team Alpha Portfolios For Retirement: When Is Enough, Enough? 6:41 a.m. Dec. 25, 2013 - Seeking Alpha
Investing In A Rising Interest Rate Environment 11:55 a.m. Dec. 23, 2013 - Seeking Alpha
Will Galena's Post-Holiday Charm Continue? 11:51 a.m. Dec. 19, 2013 - Seeking Alpha
Trade-Ideas: Galena Biopharma (GALE) Is Today's "Perilous Reversal" Stock 10:12 a.m. Dec. 12, 2013 - TheStreet.com
3 Breast Cancer Drugs That Could Boost Your Portfolio 4:45 p.m. Dec. 11, 2013 - Seeking Alpha
Today's Dead Cat Bounce Stock: Galena Biopharma (GALE) 3:01 p.m. Dec. 11, 2013 - TheStreet.com
Can The Uptrend Continue for Galena Biopharma Inc. (GALE)? - Tale of the Tape 7:15 a.m. Dec. 10, 2013 - Zacks.com
4 Reasons Why Galena Biopharma Is Headed Higher 1:05 p.m. Dec. 4, 2013 - Wall St. Cheat Sheet
Perilous Reversal Stock: Galena Biopharma (GALE) 11:40 a.m. Dec. 3, 2013 - TheStreet.com
Galena rallies, article calls pipeline "rich" 11:31 a.m. Dec. 2, 2013 - Seeking Alpha
Biotech Stocks Partying Like It's 1999 7:00 a.m. Dec. 2, 2013 - TheStreet.com
Galena: A Pipeline Rich For Investors 2:46 a.m. Dec. 2, 2013 - Seeking Alpha
2 Team Alpha Portfolio Updates: Selling Several Losing Positions And Performance Reviews 1:37 a.m. Dec. 2, 2013 - Seeking Alpha
Biotech Stocks With Promise 11:00 a.m. Nov. 29, 2013 - RealMoney.com

Special Stocks Analysis: ImmunoCellular Therapeutics, Vodafone Group, BlackBerry Ltd, Galena Biopharma Inc 10:04 a.m. Dec. 24, 2013 - ACCESSWIRE
Technical Research on Equities: Ariad Pharma, MannKind, Galena Biopharma, and Novavax 8:00 a.m. Dec. 23, 2013 - PR Newswire
Clinical Studies Updates, and Stock Price Movements - Research Report on Merck, Select Medical Holdings, Galena Biopharma, Dendreon, and Echo Therapeutics 8:00 a.m. Dec. 16, 2013 - PR Newswire
TrendingWallStreet.com Begins Volume Coverage on FB, TC, OCZ, and GALE 12:21 a.m. Dec. 5, 2013 - ACCESSWIRE
Breakfast News: Hewlett-Packard Company, Alpha Natural Resources, Yahoo! Inc, Galena Biopharma 8:51 a.m. Dec. 4, 2013 - ACCESSWIRE
Corporate News, Acquisitions: Herbalife Ltd, 3D Systems Corporation, Federal National Mortgage Association, Galena Biopharma Inc, Oncomed Pharmaceuticals 8:44 a.m. Dec. 4, 2013 - PR Newswire
Galena Biopharma to Present at the Oppenheimer 24th Annual Healthcare Conference 7:05 a.m. Dec. 4, 2013 - GlobeNewswire
Healthcare Sector Announce Awards, Conference Participation, Partnerships, and Closure of Public Offering - Research Report on Regeneron, Alnylam, Galena Biopharma, Amedisys, and Aeterna Zentaris 8:00 a.m. Dec. 3, 2013 - PR Newswire
TrendingWallStreet.com Begins Volume Coverage on MYGN, FNMA, ABX, and GALE 12:26 a.m. Dec. 3, 2013 - ACCESSWIRE
Pre-Market Breakdown: Galena Biopharma Inc., Novavax Inc., Ariad Pharma Inc., and MannKind Corp. 8:00 a.m. Nov. 27, 2013 - PR Newswire
Galena Biopharma to Present at the 25th Annual Piper Jaffray Healthcare Conference 7:05 a.m. Nov. 26, 2013 - GlobeNewswire
HIMX, GALE, INTC and NVGN added to NASDAQ Active Stock Watch List at GSR 10:16 a.m. Nov. 25, 2013 - ACCESSWIRE
Settlement Agreement, Presentation of Trial Results, and Stock Price Update - Research Report on Johnson & Johnson, Mettler-Toledo, Galena Biopharma, Dendreon, and Amedisys 8:00 a.m. Nov. 25, 2013 - PR Newswire
Quarterly Reports and Events - Research Report on Mettler-Toledo, Galena Biopharma, Achillion, Wright Medical, and OXiGENE 8:00 a.m. Nov. 15, 2013 - PR Newswire
ZLCS, CLRX, DSCO and GALE added to NASDAQ Active Stock Watch List at GSR 10:19 a.m. Nov. 11, 2013 - ACCESSWIRE
Galena Biopharma Announces Initial Results From the Folate Binding Protein Vaccine Phase 1 Trial at the Society for Immunotherapy of Cancer Conference 7:05 a.m. Nov. 11, 2013 - GlobeNewswire
Galena Biopharma Reports Third Quarter 2013 Results 4:35 p.m. Nov. 6, 2013 - GlobeNewswire
Closing of Over-Allotment Options, Receiving Orphan Drug Designations, Release of Clinical Data, and Obtaining Important Patents - Research Report on Galena, Zalicus, Infinity, Stemline and Insmed 8:00 a.m. Nov. 5, 2013 - PR Newswire
Morning Research: Ariad Pharma Inc., MannKind Corp., Novavax Inc., and Galena Biopharma Inc. 1:30 p.m. Nov. 1, 2013 - PR Newswire
New Small Cap Reports on RXII, APPA and TRTC 2:20 a.m. Nov. 1, 2013 - ACCESSWIRE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CVS Health Boosts 2026 Guidance Amid Revenue Jump

A Solid Quarter for CVS Health CVS Health Corporation has once again turned heads with its third-quarter 2026 results. When you're pulling $108.4 billion in quarterly revenue, up 5.4% from last year, folks notice. Adjusted earnings hit $2.09 per share, climbing a respectable 30% from $1.60 the year before. The cherry on top? A big fat boost in 2026 guidance, signaling...

NACCO Navigates Strong 2026 Q3, Faces Solar Cost Hurdles

Rolling With NACCO's Financial Punches Well, folks, when it rains, it pours—numbers that is. NACCO Industries just laid out their Q3 results for all to gawk at, and it's a mixed bag of triumphs and tussles. You got a gross profit of $11.8 million, a sweet 18% jump on the same quarter last year. Now, you're talking about revenue muscle, and there it is. Income before...

Natuvion and PwC's IT Roadbook: A Game-Changer?

IT Transformations: A Tough Nut to Crack Transforming IT systems isn't just about plugging in new tech. It's a beast of a task, fraught with pitfalls and peopled with ambitious project managers hoping to dodge them. Natuvion and PricewaterhouseCoopers (PwC) have put together a book that could be the guide folks need when wading into these complex waters. The 'Why' of...

AbsenceSoft's AI Leave Planner Tackles HR Headaches

Pioneering Technology in Leave Management AbsenceSoft is rolling out a tool that's about to shake up the HR world in a big way. MyAbsence, powered by AbsenceSoftAI, seems ready to cut down on the common confusions that send HR folks spinning around like they're in a two-step dance competition, juggling leave requests and compliance checks. It's all about getting the...

Key Insights on Effective Commercial Property Management

Unpacking Commercial Property Management Essentials Dive into the nitty-gritty of what keeps commercial properties ticking like a well-oiled machine, courtesy of Jayna D. Byrnes' expertise. If you're thinking it's all about collecting rent checks, think again. Byrnes, who helms KCM Commercial Property Management, lays out the full spectrum of services that transform a...

Sungrow's 1,243 MWh BESS: 20-Day Commissioning Feat

Breaking Barriers in Energy Storage Innovation Sungrow's latest swift 20-day expedition in the land of renewable energy is a bit of a jaw-dropper. They've whipped up Europe's largest operational Battery Energy Storage System (BESS) at Hams Hall, and they did it at breakneck speed. This ain't just another plug-and-play; it's the 1,243 MWh goliath that's set up to be a key...

Fluence Energy Lawsuit: Investors Face Key Deadline

Fluence Energy Under Fire Fluence Energy, Inc., ain't having the best of times, folks. If you've been keeping an eye on the stock ticker NASDAQ:FLNC, you probably felt the shiver when the news of a securities fraud class action lawsuit hit the wire. This ain't about some minor slip-up. These allegations are rocking the boat hard. What's at Stake for Investors? Here's the...

Zeelo Strengthens West Coast Expansion with Zoss Hire

Zeelo's got itself a new captain steering its West Coast ship, and it’s none other than transportation whiz Gillian Zoss. Now, when a company like Zeelo pulls a move like this, it's worth taking a moment to chew over the implications. Zeelo's been known for shaking up how folks think about moving people—employees, kids to schools, you name it—their model's rattled a...

Johnsonville's Election Effort: Sausage for Dinner Gains Momentum

Sausage Politics: A Tasty New Agenda Well, ain't that something? A sausage campaign running parallel to the midterms wasn't exactly on my bingo card. But here we are, America, dealing with a 'Sausage Tsunami.' This cheeky strategy from Johnsonville sure packs a punch, leveraging electoral fatigue to put sausage right where they want it: on your dinner plate. The Campaign...

Dissecting the USDOT's New DBE/ACDBE Final Rule

The Landscape Shift in DBE/ACDBE Compliance When the USDOT decided to roll out their Final Rule in September, they didn't just shuffle the deck - they reshuffled the whole game for the Disadvantaged Business Enterprise (DBE) and Airport Concession Disadvantaged Business Enterprise (ACDBE) programs. Public agencies and businesses from coast to coast have been left...